RXRX
NASDAQ · Biotechnology
Recursion Pharmaceuticals-A
$3.56
+0.06 (+1.71%)
Performance
1D
+1.14%
1W
-7.05%
1M
-9.87%
3M
+8.21%
6M
+9.20%
1Y
-22.94%
YTD
-15.24%
Open$3.55
Previous Close$3.50
Day High$3.66
Day Low$3.48
52W High$5.24
52W Low$2.77
Volume—
Avg Volume22.06M
Market Cap2.19B
P/E Ratio—
EPS$-0.89
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$3.77
Below
SMA 200
$3.50
Above
RSI (14)
47.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
13 analysts
Price Target
+711.8% upside
Current
$3.56
$3.56
Target
$28.90
$28.90
$21.05
$28.90 avg
$39.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 102.87M | 83.43M | 309.68M |
| Net Income | -888,180,183 | -648,306,702 | -18,426,824 |
| Profit Margin | -863.4% | -820.2% | -6.0% |
| EBITDA | -836,898,718 | -644,812,475 | -21,116,374 |
| Free Cash Flow | — | — | -13,211,156 |
| Rev Growth | +23.3% | +23.3% | +0.8% |
| Debt/Equity | 0.02 | 0.02 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |